These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37550903)

  • 1. New Inspirations from Discovering the Molecular Target of Metformin.
    Zhao C
    Curr Pharm Des; 2023; 29(23):1863-1866. PubMed ID: 37550903
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin action on AMP-activated protein kinase: a translational research approach to understanding a potential new therapeutic target.
    Boyle JG; Salt IP; McKay GA
    Diabet Med; 2010 Oct; 27(10):1097-106. PubMed ID: 20854376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin as an Anticancer Agent.
    Vancura A; Bu P; Bhagwat M; Zeng J; Vancurova I
    Trends Pharmacol Sci; 2018 Oct; 39(10):867-878. PubMed ID: 30150001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metformin - new data for an "old", but efficient, safe and reliable antidiabetic drug].
    Winkler G
    Orv Hetil; 2016 Jun; 157(23):882-91. PubMed ID: 27233831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer research. Cancer prevention with a diabetes pill?
    Taubes G
    Science; 2012 Jan; 335(6064):29. PubMed ID: 22223788
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation.
    Di Fusco D; Dinallo V; Monteleone I; Laudisi F; Marafini I; Franzè E; Di Grazia A; Dwairi R; Colantoni A; Ortenzi A; Stolfi C; Monteleone G
    Clin Sci (Lond); 2018 Jun; 132(11):1155-1168. PubMed ID: 29540537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism Underlying Metformin Action and Its Potential to Reduce Gastric Cancer Risk.
    Lan WH; Lin TY; Yeh JA; Feng CL; Hsu JT; Lin HJ; Kuo CJ; Lai CH
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Like Growth Factor 1/Mammalian Target of Rapamycin and AMP-Activated Protein Kinase Signaling Involved in the Effects of Metformin in the Human Endometrial Cancer.
    Cai D; Sun H; Qi Y; Zhao X; Feng M; Wu X
    Int J Gynecol Cancer; 2016 Nov; 26(9):1667-1672. PubMed ID: 27654259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells
    Li Z; Ding Q; Ling LP; Wu Y; Meng DX; Li X; Zhang CQ
    World J Gastroenterol; 2018 Feb; 24(7):819-832. PubMed ID: 29467552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An energetic tale of AMPK-independent effects of metformin.
    Miller RA; Birnbaum MJ
    J Clin Invest; 2010 Jul; 120(7):2267-70. PubMed ID: 20577046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of metformin on glomerular podocytes in diabetes.
    Rogacka D; Piwkowska A
    Biochem Pharmacol; 2021 Oct; 192():114687. PubMed ID: 34274355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: fifty-two not out.
    Campbell IW
    J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
    [No Abstract]   [Full Text] [Related]  

  • 14. Metformin in cancer therapy: a new perspective for an old antidiabetic drug?
    Ben Sahra I; Le Marchand-Brustel Y; Tanti JF; Bost F
    Mol Cancer Ther; 2010 May; 9(5):1092-9. PubMed ID: 20442309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation.
    Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS
    Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Activates AMPK through the Lysosomal Pathway.
    Zhang CS; Li M; Ma T; Zong Y; Cui J; Feng JW; Wu YQ; Lin SY; Lin SC
    Cell Metab; 2016 Oct; 24(4):521-522. PubMed ID: 27732831
    [No Abstract]   [Full Text] [Related]  

  • 17. Metformin and the Gut Microbiome in Diabetes.
    Devaraj S; Venkatachalam A; Chen X
    Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of metformin regulation in central nervous system: Progression and future perspectives.
    Cao G; Gong T; Du Y; Wang Y; Ge T; Liu J
    Biomed Pharmacother; 2022 Dec; 156():113686. PubMed ID: 36244266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.
    Eisenreich A; Leppert U
    Curr Med Chem; 2017; 24(31):3397-3412. PubMed ID: 28393693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effects of metformin in various cardiovascular diseases: Clinical evidence and AMPK-dependent mechanisms.
    Bu Y; Peng M; Tang X; Xu X; Wu Y; Chen AF; Yang X
    J Cell Mol Med; 2022 Oct; 26(19):4886-4903. PubMed ID: 36052760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.